Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09OWC
|
||||
Former ID |
DIB002917
|
||||
Drug Name |
SKLB-010
|
||||
Synonyms |
Thiazolidinediones (inflammation), Sichuan University
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [543390] | ||
Company |
Sichuan University
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C\1(=C\c2ccc(cc2)OC)/C(=O)NC(=O)S1
|
||||
Target and Pathway | |||||
Target(s) | Nitric oxide synthase, inducible | Target Info | Modulator | [543390] | |
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
KEGG Pathway | Arginine biosynthesis | ||||
Arginine and proline metabolism | |||||
Metabolic pathways | |||||
Calcium signaling pathway | |||||
HIF-1 signaling pathway | |||||
Peroxisome | |||||
Salmonella infection | |||||
Pertussis | |||||
Leishmaniasis | |||||
Chagas disease (American trypanosomiasis) | |||||
Toxoplasmosis | |||||
Amoebiasis | |||||
Tuberculosis | |||||
Pathways in cancer | |||||
Small cell lung cancer | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.